期刊文献+

GK大鼠胃转流术后空腹血糖及骨骼肌SIRT3酶变化的实验研究 被引量:2

Changes in fasting blood glucose and skeletal muscle SIRT3 enzyme in GK rats after undergoing gastric bypass operation
下载PDF
导出
摘要 目的:探讨GK大鼠行胃转流术后空腹血糖及骨骼肌SIRT3酶的变化及意义;方法:24只Goto-Kakizaki(GK)大鼠随机分为手术组(operation group OG组,假手术组(sim-operation group SG组)和对照组(control group CG组);OG组大鼠行胃转流手术,SG组大鼠行假手术,CG组仅作术前对照,OG组和SG组分别测定术前、术后48h和1、2及4周空腹血糖水平,术后4周处死取大腿部骨骼肌用western blot法半定量测定其SIRT3酶值;CG组监测空腹血糖水平,4周后处死同法测定大腿骨骼肌SIRT3酶值。结果:术前3组大鼠空腹血糖水平相仿,术后OG组血糖水平进行性下降,2周后血糖水平稳定,与SG组和CG组比较明显降低(P﹤0.05),SG组与CG组各时相空腹血糖水平差异无统计学意义(P﹥0.05);OG组术后骨骼肌SIRT3酶表达与明显增加,与SG组和CG组比较差异有统计学意义;结论:胃转流术可降低GK大鼠空腹血糖,骨骼肌SIRT3酶表达的增加可能是其糖尿病改善的机制之一。 Objective: To investigate the changes m tasting blood glucose ane s^etetat muscle SIRT3 enzyme in GK rats after undergoing gastric bypass operation. Methods:Twenty-four Goto-Kakizaki (GK) rats were randomly divided into the operation group (OG group, n=8), sham group (SG group, n m-8) and the control group (CG group, n-~8). OG group were subjected to gastric bypass surgery, SG rats underwent a sham surgery, and CG group served as preoperative control. 48 h and 1, 2 and 4 weeks of fasting blood glucose levels of the OG group and SG groups were measured. Four weeks after the surgery, rats were sacrificed and the thigh skeletal muscle was taken out, semi-quantitative determination of SIRT3 levels were measured with western blot method. Results. The preoperative fasting glucose levels were simi- lar among the three groups, after surgery, glucose level of OG group declined, and achieved stable 2weeks later, showing significant difference from group SG and CG. (P^0.05). No significant difference in fasting blood glucose levels was observed between group SG and CG (P^0.05). The skeletal muscle SIRT3 enzyme expression level of the OG group were significantly increased compared with the SG group and CG group (P〈0.05). 0onclusion. The gastric bypass can reduce fasting blood glucOse level in GK rats, increase in skeletal muscle SIRT3 enzyme expression might be one of the mechanisms by which dia- betes can be improved.
出处 《海南医学院学报》 CAS 2013年第2期145-147,151,共4页 Journal of Hainan Medical University
基金 中国高校医学期刊临床专项资金项目(112210501)~~
关键词 胃转流术 Goto—Kakizaki大鼠 SIRT3酶 Gastric bypass surgery Goto-Kakizaki rat SIRT3 enzyme
  • 相关文献

参考文献12

  • 1Payne JH,DeWind LT. Surgical treatment of obesity[J].American Journal of Surgery,1969,(02):141-147.
  • 2Scott H W Jr,Dean R. Considerations in the use of Jejunoileal bypass in patients with morbid obesity[J].Annals of Surgery,1973,(06):323-335.
  • 3Patriti A,Facchiano E,Donini A. Effect of duodenaljejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for and old disease[J].Annals of Surgery,2004,(02):388-389.
  • 4Cummings DE,O verduin J,Foster-Schubert KE. Gastric bypass for obesity:M ecganism of weight loss and diabetes resolution[J].J C lin Endocrin M etab,2004,(06):2608-2615.
  • 5Schauer PR,Burguera B,Ikramuddin S. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus[J].Annals of Surgery,2003,(04):467-484.
  • 6Clements RH,Gonzalez QH,Long C I. Hormonal changes after Roux-en-Y gastric bypass for morbid obesity and the control of type-Ⅱ diabetes mellitus[J].Annals of Surgery,2004,(01):1-4.
  • 7Sugerman HJ,Wolfe LG,Sica DA. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss[J].Annals of Surgery,2003,(06):751-756.doi:10.1097/00000658-200306000-00002.
  • 8Flatt PR. Effective surgical treatment of obesity may be mediated by ablation of the lipogenic gut hormone gastric inhibitory polypeptide(GIP):evidence and clinical opportunity for development of new obesity-diabetes drug[J].Diab Vasc Dis Res,2007,(02):151-153.
  • 9Bellizzi D,Rose C,Cavalcante P. Anovel VNTR enhancer within the SIRT3 gene,a human homologue of SIR2,is associated with survival at oldest ages[J].Genomics,2005,(02):258-263.
  • 10Yechoor V K,Patti M E,Ueki K. Distinct pathways of insulin-regulated versus diabetes regulated gene expression:An in vivo analysis in MIRKO mice[J].Proceedings of the National Academy of Sciences(USA),2004,(47):16525-16530.doi:10.1073/pnas.0407574101.

同被引文献14

  • 1Camastra S. Bariatric surgery as a treatment of type 2 diabetes[J]. Recenti Prog Med, 2011,102(2): 82-87.
  • 2Huttl TP, Karl-Walter J. Bariatric surgery: fighting o- besity and diabetes with a scalpel[J]. MMW Fortschr Med, 2010,152(22): 28.
  • 3Tejirian T, Jensen C, Dutson E. Bariatric surgery and type 2 diabetes mellitus: surgically induced remission [J]. J Diabetes Sei Technol, 2008, 2(4) : 685-691.
  • 4Kashyap SR. Bariatric surgery for type 2 diabetes: weighing the impact for obese patients[J]. Cleve Clin J Med, 2010,77(7): 468-476.
  • 5Schernthaner G, Morton JM. Bariatric surgery in pa- tients with morbid obesity and type 2 diabetes[J]. Dia- betes Care, 2008,31( Suppl 2): S297-302.
  • 6de Aquino LA,Pereira SE, de Souza Silva J ,et al. Bari- atric surgery impact on body composition after Roux- en-Y gastric bypass[J]. Obes Surg, 2012 ,22 (2)..195- 200.
  • 7Marantos G, Daskalakis M, Karkavitsas N, et al. Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with re- strictive bariatric surgery[J]. World J Surg, 2011, 35 (9) .. 2022-2030.
  • 8Unick JL, Bond DS, Jakicic JM, et al. Comparison of Two Objective Monitors for Assessing Physical Activity and Sedentary Behaviors in Bariatric Surgery Patients. Obes Surg, 2012,22(3) :347-352.
  • 9Giralt A, Villarroya F. SIRT3, a pivotal actor in mito- chondrial functions: metabolism, cell death and aging [J]. Biochem J, 2012,444(1) : 1-10.
  • 10Jing E, Emanuelli B, Hirschey MD, et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insu- lin signaling via altered mitochondrial oxidation and re- active oxygen species production[J]. Proc Natl Acad Sci U S A, 2011,108(35): 14608-14613.

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部